Grant funding disruptions affected about one in 30 trials, according to a research letter published online Nov. 17 in JAMA Internal Medicine. Vishal R. Patel, M.D., M.P.H., from Harvard Medical School ...

Identify DCT growth opportunities through market segmentation, competitive rankings, technology trends, strategic alliances, M&A, venture funding and ESG insights.Dublin, Oct. 09, 2026 (GLOBE NEWSWIRE ...

The 2025 ASCO Annual Meeting showcased groundbreaking oncology research and treatments, fostering collaboration among leading experts in the field. The 2025 American Society of Clinical Oncology (ASCO ...

2025 was a year when Hip-Hop met the courtroom head-on—marked by explosive trials, shocking acquittals and civil judgments. Grouchy Greg Watkins (@GrouchyGreg) • Jan 2, 2026 @ 9:30 AM Add as a ...

The SISAQOL-IMI consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has published a paper in The Lancet Oncology outlining how ...

A new commentary in the medical journal Pediatrics raises important concerns about the ethics of stopping clinical trials before they are completed, especially when those studies involve children and ...

The conduct of clinical trials poses ethical questions for any medical condition, and gout is no exception, including some of its own peculiarities. In 2016, Robert H. Shmerling, MD, of Harvard ...

A trial will begin this week for Dalton Perkins, a Sturgeon man accused of second-degree murder during an argument in 2025.